Shu Wang

University of Florida Health, University of Florida

Papers

Total Citations

H-Index

About

Shu Wang is a clinical researcher specializing in gynecologic oncology, with a particular focus on endometrial cancer management across diverse patient populations. Their work addresses critical gaps in the literature by examining outcomes in groups historically underrepresented in clinical trials, including elderly women and obese patients — two populations whose care presents unique clinical challenges. Among Wang's most notable contributions is their investigation into venous thromboembolism (VTE) risk following robotic-assisted hysterectomy in obese patients with endometrial cancer, a study that has garnered 13 citations and directly informs perioperative prophylaxis decision-making. Complementing this, their research on oncologic outcomes in women aged 70 and older — analyzing 121 patients who underwent hysterectomy — provides much-needed evidence to guide the management of a population often excluded from landmark trials, accumulating 8 citations since its 2022 publication. Wang's research collectively advances the field by translating real-world clinical data into actionable insights for gynecologic surgeons and oncologists. By championing the study of vulnerable and understudied patient groups, Wang's work helps narrow evidence gaps and supports more equitable, personalized cancer care for women with endometrial carcinoma.